GLP-3 RT
Triple GIP/GLP-1/glucagon agonist · Metabolic / GLP-1 Research
Triple-agonist research peptide for next-gen metabolic models.
GLP-3 RT is a triple receptor agonist (GIP, GLP-1 and glucagon) under investigation in metabolic research. Research use only; not for human consumption.
Available sizes: 10mg, 15mg, 24mg, 30mg, 48mg, 60mg · Form: Lyophilized powder
Documented purity: 99.6% HPLC. Every lot ships with an independent third-party Certificate of Analysis.
How it is studied
- Triple agonism (Incretin) - Simultaneous activity at three receptors is the defining feature in comparative pharmacology studies.
- Glucagon receptor (Metabolic) - Added glucagon-receptor activity is studied for effects on energy expenditure in preclinical models.
- Adiposity models (Metabolic) - Explored in rodent adiposity endpoints. Illustrative, not a human efficacy claim.
Research Use Only. Not for human or veterinary use.